2006
DOI: 10.1021/ja065557e
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of β-Amyloid Fibrillization by Directed Evolution of a β-Sheet Presenting Miniature Protein

Abstract: We describe the directed evolution of a miniature beta-sheet protein for targeting beta-amyloid oligomers implicated in Alzheimer's disease. Circular dichroism spectroscopy, thermal denaturation experiments, and immunoglobulin binding assays established that our beta-amyloid-targeted miniature protein, TJ10, presents a well-folded thermostable beta-sheet. TJ10 was found to prevent beta-amyloid fibrillization at stoichiometric concentrations and was also an effective inhibitor at substoichiometric concentration… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
47
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 45 publications
(48 citation statements)
references
References 29 publications
1
47
0
Order By: Relevance
“…The selection of alanine or proline at position 24 can be rationalized Short peptides, which are homologous to A␤ but contain proline residues as ␤-sheet blockers, have been developed as fibrillogenesis inhibitors (16). The aim of this and related peptide-and protein-based approaches that target A␤ aggregation is to bind the hydrophobic part of A␤ by exploiting the same intermolecular interactions formed in A␤ self-assembly, e.g., ␤-sheet backbone hydrogen bonds, and to consequently disrupt the potential for further ␤-sheet extension (15)(16)(17)29). Although no structure of a ␤-sheet breaker peptide in complex with A␤ has been reported, certain aspects of the concept appear to be reflected in the Z A␤3 :A␤(1-40) interaction: The Z A␤3 ␤-strands cap the edges of the A␤(1-40) ␤-sheet; the strands are short and terminated on their C-terminal side by a proline and on the N-terminal side by a sequence region selected to have little propensity for either ␣-or ␤-structure, resulting in an inability to serve as a template for further ␤-sheet extension.…”
Section: Resultsmentioning
confidence: 99%
“…The selection of alanine or proline at position 24 can be rationalized Short peptides, which are homologous to A␤ but contain proline residues as ␤-sheet blockers, have been developed as fibrillogenesis inhibitors (16). The aim of this and related peptide-and protein-based approaches that target A␤ aggregation is to bind the hydrophobic part of A␤ by exploiting the same intermolecular interactions formed in A␤ self-assembly, e.g., ␤-sheet backbone hydrogen bonds, and to consequently disrupt the potential for further ␤-sheet extension (15)(16)(17)29). Although no structure of a ␤-sheet breaker peptide in complex with A␤ has been reported, certain aspects of the concept appear to be reflected in the Z A␤3 :A␤(1-40) interaction: The Z A␤3 ␤-strands cap the edges of the A␤(1-40) ␤-sheet; the strands are short and terminated on their C-terminal side by a proline and on the N-terminal side by a sequence region selected to have little propensity for either ␣-or ␤-structure, resulting in an inability to serve as a template for further ␤-sheet extension.…”
Section: Resultsmentioning
confidence: 99%
“…192 Several groups have subsequently employed combinatorial libraries to select short peptides that block amyloid formation and, in some cases, stabilize non-amyloid aggregates. [193][194][195][196][197] (Phage display and related techniques are also commonly used to select binding proteins, as discussed in other sections of this article. )…”
Section: Peptide Inhibitor Selection From Combinatorial Librariesmentioning
confidence: 99%
“…Amyloid-␤(1-40) Preparation-A␤(1-40) fibrils were formed as described previously (23,46). Briefly, 250 l of a caspase activity buffer (20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 , 1.5% sucrose, 10 mM DTT, 0.1% CHAPS) was added to the lyophilized solid to 50 M. The peptide was agitated at 37°C for 4 -6 h. …”
Section: Procaspase-3 Trans-activation Assaysmentioning
confidence: 99%